Literature DB >> 21776531

Making carbon nanotubes biocompatible and biodegradable.

Alberto Bianco1, Kostas Kostarelos, Maurizio Prato.   

Abstract

Carbon nanotubes are promising nanomaterials with great potential in the field of nanomedicine for both therapeutic and diagnostic applications. Different approaches have been developed to render this material biocompatible and to modulate any ensuing toxic effects. In the context of medical use, although chemically functionalised carbon nanotubes display reduced toxicity, they are still considered with scepticism due to their perceived non-biodegradability. Recently, it has been demonstrated that functionalised carbon nanotubes can be degraded by oxidative enzymes. This finding is offering a new perspective for the development of carbon nanotubes in medicine. This article highlights recent advances that can act as paradigm-shifts towards the design of biocompatible and biodegradable functionalised carbon nanotubes and allow their translation into the clinic. This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21776531     DOI: 10.1039/c1cc13011k

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  50 in total

1.  Rapid detection of polyethylene glycol sonolysis upon functionalization of carbon nanomaterials.

Authors:  Vasanth S Murali; Ruhung Wang; Carole A Mikoryak; Paul Pantano; Rockford Draper
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-06

2.  Functionalized multiwalled carbon nanotubes as ultrasound contrast agents.

Authors:  Lucia Gemma Delogu; Gianpaolo Vidili; Enrica Venturelli; Cécilia Ménard-Moyon; Maria Antonietta Zoroddu; Giovannantonio Pilo; Paola Nicolussi; Ciriaco Ligios; Davide Bedognetti; Francesco Sgarrella; Roberto Manetti; Alberto Bianco
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

3.  Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications.

Authors:  Wanji Seo; Alexandr A Kapralov; Galina V Shurin; Michael R Shurin; Valerian E Kagan; Alexander Star
Journal:  Nanoscale       Date:  2015-05-21       Impact factor: 7.790

4.  The impact of subcellular location on the near infrared-mediated thermal ablation of cells by targeted carbon nanotubes.

Authors:  Vasanth S Murali; Ruhung Wang; Carole A Mikoryak; Paul Pantano; Rockford K Draper
Journal:  Nanotechnology       Date:  2016-09-15       Impact factor: 3.874

Review 5.  A review of organic and inorganic biomaterials for neural interfaces.

Authors:  Pouria Fattahi; Guang Yang; Gloria Kim; Mohammad Reza Abidian
Journal:  Adv Mater       Date:  2014-03-26       Impact factor: 30.849

6.  Nanomaterials for (Nano)medicine.

Authors:  Silvia Marchesan; Maurizio Prato
Journal:  ACS Med Chem Lett       Date:  2012-12-11       Impact factor: 4.345

Review 7.  Safe clinical use of carbon nanotubes as innovative biomaterials.

Authors:  Naoto Saito; Hisao Haniu; Yuki Usui; Kaoru Aoki; Kazuo Hara; Seiji Takanashi; Masayuki Shimizu; Nobuyo Narita; Masanori Okamoto; Shinsuke Kobayashi; Hiroki Nomura; Hiroyuki Kato; Naoyuki Nishimura; Seiichi Taruta; Morinobu Endo
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

Review 8.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

Review 9.  Nanoparticles, lung injury, and the role of oxidant stress.

Authors:  Amy K Madl; Laurel E Plummer; Christopher Carosino; Kent E Pinkerton
Journal:  Annu Rev Physiol       Date:  2013-11-06       Impact factor: 19.318

Review 10.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.